In contrast, EGFR mutations in non-small cell lung cancer cells render them more susceptible to SLC7A11 inhibition or cysteine deprivation because intracellular cysteine promoted survival EGFR-mutant cells independent of GSH-relater redox balance [42]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.